This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
TriMas (TRS) Closes Omega Buyout, Fortifies Packaging Business
by Zacks Equity Research
TriMas (TRS) completes its acquisition of Omega Plastics, the third addition to its packaging platform in two years.
TriMas (TRS) to Buy Omega & TFI, Expands Packaging & Aerospace
by Zacks Equity Research
TriMas' (TRS) buyouts help it expand its product offerings in the packaging and aerospace business.
TriMas (TRS) Q3 Earnings and Revenues Lag Estimates
by Zacks Equity Research
TriMas (TRS) delivered earnings and revenue surprises of -5.00% and -1.14%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
TriMas (TRS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
TriMas (TRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Barnes Group (B) to Gain From Strong End Markets Amid Woes
by Zacks Equity Research
Barnes Group (B) is poised to gain from strength across its businesses, solid operational execution, and shareholder-friendly policies. Weakness in aerospace aftermarket business remains a woe.
TriMas (TRS) Bets on Solid Demand for Packaging & Acquisitions
by Zacks Equity Research
TriMas (TRS) will benefit from increasing demand for products used in personal care and home care applications supported by increased global awareness for hygiene even when the pandemic fades.
Here's Why TriMas (TRS) is a Strong Value Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks.com featured highlights include: Walmart, Vertex Pharma, Medical Properties Trust, TriNet Group and TriMas Corp
by Zacks Equity Research
Zacks.com featured highlights include: Walmart, Vertex Pharma, Medical Properties Trust, TriNet Group and TriMas Corp
Rising P/E: A Trick to Land on 5 Winning Stocks
by Sanghamitra Saha
Want to try a different approach? Tap five stocks with increasing P/E ratios.
TriMas (TRS) Q2 Earnings Top Estimates, Revenues Lag, Up Y/Y
by Zacks Equity Research
TriMas' (TRS) Q2 revenues and earnings improve year over year on higher sales in all segments. Assuming this trend to continue, it expects earnings per share in the range of $2.15 to $2.30 in 2021.
TriMas (TRS) Beats Q2 Earnings Estimates
by Zacks Equity Research
TriMas (TRS) delivered earnings and revenue surprises of 8.77% and -2.16%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
TriMas (TRS) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
TriMas (TRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
TriMas (TRS) Packaging Segment Invests in Manufacturing Unit
by Zacks Equity Research
TriMas' (TRS) Packaging segment is building a technologically advanced facility in Ohio that will help support future growth, drive operational excellence, and lower lead times to customers.
Zacks Industry Outlook Highlights: Norsk Hydro, Timken, Worthington Industries, Mueller Industries and TriMas
by Zacks Equity Research
Zacks Industry Outlook Highlights: Norsk Hydro, Timken, Worthington Industries, Mueller Industries and TriMas
5 Metal Fabrication Stocks to Watch Amid Supply Chain Woes
by Madhurima Das
While demand in the Zacks Metal Products - Procurement and Fabrication industry's end markets remains strong, it remains constrained by supply chain challenges and high input costs. In this scenario, NHYDY, TKR, WOR, MLI and TRS are betting on cost management and automation to drive margins.
Packaging to Offset Weakness in TriMas' (TRS) Other Markets
by Zacks Equity Research
TriMas' (TRS) Packaging group is riding on increasing demand amid the COVID-19 pandemic, which will help offset the impact of lower air travel on its Aerospace segment.
Bear of the Day: Century Aluminum (CENX)
by David Bartosiak
Could the commodity boom be turning to a commodity bust?
Worthington (WOR) Boosts Laser Welding With BlankLight Buyout
by Zacks Equity Research
Worthington's (WOR) buyout of the U.S. BlankLight business of Shiloh Industries is anticipated to enhance the company's laser-welded products and steel processing businesses.
E-commerce Demand, Strategic Initiatives to Aid Grainger (GWW)
by Zacks Equity Research
Grainger (GWW) is focused on outpacing the market by focusing on the strategic activities and improving customer relationships.
The Zacks Analyst Blog Highlights: Deere & Co, Caterpillar, AGCO Corp, TriMas Corp and Dover Corp
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Deere & Co, Caterpillar, AGCO Corp, TriMas Corp and Dover Corp
5 Top Stocks to Buy as Industrial Output Continues to Expand
by Ritujay Ghosh
People have been spending more on goods than services during the pandemic, which is driving industrial output, thus helping stocks like Caterpillar (CAT), Deere & Company (DE) and Dover Corporation (DOV).
Kaiser (KALU) Prices Notes, to Use Proceeds for Note Redemption
by Zacks Equity Research
Kaiser (KALU) prices $550 million worth of senior notes offerings. It intends on using the proceeds for funding the redemption of existing senior notes and satisfying general corporate purposes.
TriMas (TRS) Q1 Earnings and Revenues Beat Estimates, Up Y/Y
by Zacks Equity Research
Robust demand in TriMas' (TRS) Packaging segment led to improved first-quarter 2021 revenues despite ongoing weakness in some end markets.
TriMas (TRS) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
TriMas (TRS) delivered earnings and revenue surprises of 5.26% and 5.05%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
TriMas (TRS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
TriMas (TRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.